Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2019 Oct 22;33(4):758. doi: 10.1038/s41379-019-0379-5

Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

Nicola L Lawson 1, Carly I Dix 2, Paul W Scorer 1, Christopher J Stubbs 3, Edmond Wong 2, Liam Hutchinson 4, Eileen J McCall 5, Marianne Schimpl 3, Emma DeVries 2, Jill Walker 6, Gareth H Williams 7, James Hunt 2, Craig Barker 1,✉
PMCID: PMC8075874  PMID: 31641230

Correction to: Modern Pathology

10.1038/s41379-019-0372-z

This article was erroneously published with standard licence and copyright, but it is in fact published with open access, so has a CC BY licence and the copyright line is ‘The Author(s)’. This has been updated in the original article.

Footnotes

The original article can be found online at 10.1038/s41379-019-0372-z.

Articles from Modern Pathology are provided here courtesy of Nature Publishing Group

RESOURCES